Baur, S., Ruhwedel, T., Böke, E., Kobus, Z., Lishkova, G., Wetz, C., . . . Eschrich, J. (2025). Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing 177Lu-based Peptide Receptor Radionuclide Therapy.
Chicago Style (17th ed.) CitationBaur, Simon, et al. Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing 177Lu-based Peptide Receptor Radionuclide Therapy. 2025.
MLA (9th ed.) CitationBaur, Simon, et al. Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing 177Lu-based Peptide Receptor Radionuclide Therapy. 2025.
Warning: These citations may not always be 100% accurate.